135 related articles for article (PubMed ID: 16391720)
1. Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist.
McGaraughty S; Jarvis MF
Drug News Perspect; 2005 Oct; 18(8):501-7. PubMed ID: 16391720
[TBL] [Abstract][Full Text] [Related]
2. Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.
McGaraughty S; Honore P; Wismer CT; Mikusa J; Zhu CZ; McDonald HA; Bianchi B; Faltynek CR; Jarvis MF
Br J Pharmacol; 2005 Sep; 146(2):180-8. PubMed ID: 16041397
[TBL] [Abstract][Full Text] [Related]
3. Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.
McGaraughty S; Wismer CT; Zhu CZ; Mikusa J; Honore P; Chu KL; Lee CH; Faltynek CR; Jarvis MF
Br J Pharmacol; 2003 Dec; 140(8):1381-8. PubMed ID: 14623769
[TBL] [Abstract][Full Text] [Related]
4. A-317491, a selective P2X3/P2X2/3 receptor antagonist, reverses inflammatory mechanical hyperalgesia through action at peripheral receptors in rats.
Wu G; Whiteside GT; Lee G; Nolan S; Niosi M; Pearson MS; Ilyin VI
Eur J Pharmacol; 2004 Nov; 504(1-2):45-53. PubMed ID: 15507220
[TBL] [Abstract][Full Text] [Related]
5. A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat.
Honore P; Donnelly-Roberts D; Namovic MT; Hsieh G; Zhu CZ; Mikusa JP; Hernandez G; Zhong C; Gauvin DM; Chandran P; Harris R; Medrano AP; Carroll W; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1376-85. PubMed ID: 16982702
[TBL] [Abstract][Full Text] [Related]
6. [3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.
Jarvis MF; Bianchi B; Uchic JT; Cartmell J; Lee CH; Williams M; Faltynek C
J Pharmacol Exp Ther; 2004 Jul; 310(1):407-16. PubMed ID: 15024037
[TBL] [Abstract][Full Text] [Related]
7. Painful purinergic receptors.
Donnelly-Roberts D; McGaraughty S; Shieh CC; Honore P; Jarvis MF
J Pharmacol Exp Ther; 2008 Feb; 324(2):409-15. PubMed ID: 18042830
[TBL] [Abstract][Full Text] [Related]
8. Peripheral mechanisms underlying the essential role of P2X3,2/3 receptors in the development of inflammatory hyperalgesia.
Oliveira MC; Pelegrini-da-Silva A; Tambeli CH; Parada CA
Pain; 2009 Jan; 141(1-2):127-34. PubMed ID: 19081189
[TBL] [Abstract][Full Text] [Related]
9. Investigation into the role of P2X(3)/P2X(2/3) receptors in neuropathic pain following chronic constriction injury in the rat: an electrophysiological study.
Sharp CJ; Reeve AJ; Collins SD; Martindale JC; Summerfield SG; Sargent BS; Bate ST; Chessell IP
Br J Pharmacol; 2006 Jul; 148(6):845-52. PubMed ID: 16770326
[TBL] [Abstract][Full Text] [Related]
10. P2X receptors and nociception.
Chizh BA; Illes P
Pharmacol Rev; 2001 Dec; 53(4):553-68. PubMed ID: 11734618
[TBL] [Abstract][Full Text] [Related]
11. Myocardial ischemic nociceptive signaling mediated by P2X3 receptor in rat stellate ganglion neurons.
Zhang C; Li G; Liang S; Xu C; Zhu G; Wang Y; Zhang A; Wan F
Brain Res Bull; 2008 Jan; 75(1):77-82. PubMed ID: 18158099
[TBL] [Abstract][Full Text] [Related]
12. Purinergic P2 receptors as targets for novel analgesics.
Burnstock G
Pharmacol Ther; 2006 Jun; 110(3):433-54. PubMed ID: 16226312
[TBL] [Abstract][Full Text] [Related]
13. Discovery and biological evaluation of novel cyanoguanidine P2X(7) antagonists with analgesic activity in a rat model of neuropathic pain.
Perez-Medrano A; Donnelly-Roberts DL; Honore P; Hsieh GC; Namovic MT; Peddi S; Shuai Q; Wang Y; Faltynek CR; Jarvis MF; Carroll WA
J Med Chem; 2009 May; 52(10):3366-76. PubMed ID: 19397270
[TBL] [Abstract][Full Text] [Related]
14. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
[TBL] [Abstract][Full Text] [Related]
15. A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat.
Jarvis MF; Burgard EC; McGaraughty S; Honore P; Lynch K; Brennan TJ; Subieta A; Van Biesen T; Cartmell J; Bianchi B; Niforatos W; Kage K; Yu H; Mikusa J; Wismer CT; Zhu CZ; Chu K; Lee CH; Stewart AO; Polakowski J; Cox BF; Kowaluk E; Williams M; Sullivan J; Faltynek C
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17179-84. PubMed ID: 12482951
[TBL] [Abstract][Full Text] [Related]
16. Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
Jahangir A; Alam M; Carter DS; Dillon MP; Bois DJ; Ford AP; Gever JR; Lin C; Wagner PJ; Zhai Y; Zira J
Bioorg Med Chem Lett; 2009 Mar; 19(6):1632-5. PubMed ID: 19231178
[TBL] [Abstract][Full Text] [Related]
17. Electroacupuncture and A-317491 depress the transmission of pain on primary afferent mediated by the P2X3 receptor in rats with chronic neuropathic pain states.
Wang WS; Tu WZ; Cheng RD; He R; Ruan LH; Zhang L; Gong YS; Fan XF; Hu J; Cheng B; Lai YP; Zou EM; Jiang SH
J Neurosci Res; 2014 Dec; 92(12):1703-13. PubMed ID: 25041872
[TBL] [Abstract][Full Text] [Related]
18. Characterization of N-(adamantan-1-ylmethyl)-5-[(3R-amino-pyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 antagonist in animal models of pain and inflammation.
Broom DC; Matson DJ; Bradshaw E; Buck ME; Meade R; Coombs S; Matchett M; Ford KK; Yu W; Yuan J; Sun SH; Ochoa R; Krause JE; Wustrow DJ; Cortright DN
J Pharmacol Exp Ther; 2008 Dec; 327(3):620-33. PubMed ID: 18772321
[TBL] [Abstract][Full Text] [Related]
19. P2X receptors: targets for novel analgesics?
Kennedy C
Neuroscientist; 2005 Aug; 11(4):345-56. PubMed ID: 16061521
[TBL] [Abstract][Full Text] [Related]
20. Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.
Carter DS; Alam M; Cai H; Dillon MP; Ford AP; Gever JR; Jahangir A; Lin C; Moore AG; Wagner PJ; Zhai Y
Bioorg Med Chem Lett; 2009 Mar; 19(6):1628-31. PubMed ID: 19231180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
